Product Information
TACROLIMUS 0.03% OINTMENT is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.8830 per GM under NDC 00168041730. Its NADAC has been published 592 times since Apr 22, 2015.
FDA first approved this application on Sep 9, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/g
NDC
00168041730
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA200744FDA Approved
9/9/2014
TE Code
AB
On Market Since
9/9/2014
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.03% OINTMENT has been published 592 times since Apr 22, 2015, and over the history we have for it it has declined 85.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8830 per GM |
|---|---|
| All-time high | $6.5511 (Jul 15, 2015) |
| All-time low | $0.7182 (Jul 17, 2024) |
| 52-week high | $0.9133 |
| 52-week low | $0.7954 |
| Median price | $3.3649 |
| Average price | $3.3383 |
| Largest weekly change | +68.5% (Feb 22, 2023) |
| Weeks tracked | 592 |
| Tracking since | Apr 22, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.03% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.8830 per GM (NDC 00168041730), effective Aug 19, 2026.
How has the price of TACROLIMUS 0.03% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 85.9%. It has been tracked across 592 weekly CMS publications since Apr 22, 2015.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?
Since Apr 22, 2015, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.7182 (Jul 17, 2024) to a high of $6.5511 (Jul 15, 2015), with a median of $3.3649 per GM.
Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.03% OINTMENT, is $0.7954 per GM — about 10% below TACROLIMUS 0.03% OINTMENT.
Who manufactures TACROLIMUS 0.03% OINTMENT?
TACROLIMUS 0.03% OINTMENT (NDC 00168041730) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.